{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T04:38:20Z","timestamp":1772339900819,"version":"3.50.1"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"Supplement_2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,1,15]]},"DOI":"10.1086\/499404","type":"journal-article","created":{"date-parts":[[2005,12,16]],"date-time":"2005-12-16T11:58:02Z","timestamp":1134734282000},"page":"S65-S71","source":"Crossref","is-referenced-by-count":111,"title":["Trends in Antimicrobial Resistance in Health Care\u2013Associated Pathogens and Effect on Treatment"],"prefix":"10.1093","volume":"42","author":[{"given":"L. Clifford","family":"McDonald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2006,1,15]]},"reference":[{"key":"key\n\t\t\t\t20171014021251_ref1","volume-title":"WHO global strategy for the containment of antimicrobial resistance","author":"World Health Organization","year":"2001"},{"key":"key\n\t\t\t\t20171014021251_ref2","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1086\/513766","article-title":"Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals","volume":"25","author":"Shlaes","year":"1997","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014021251_ref3","volume-title":"A public health action plan to combat antimicrobial resistance","author":"Centers for Disease Control and Prevention"},{"key":"key\n\t\t\t\t20171014021251_ref4","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1126\/science.99.2579.452","article-title":"Extraction of a highly potent penicillin inactivator from penicillin resistant staphylococci","volume":"99","author":"Kirby","year":"1944","journal-title":"Science"},{"key":"key\n\t\t\t\t20171014021251_ref5","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3201\/eid0702.010204","article-title":"The changing epidemiology of Staphylococcus aureus?","volume":"7","author":"Chambers","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20171014021251_ref6","first-page":"139","article-title":"The National Nosocomial Infections Surveillance System. Changes in the epidemiology of methicillin\/oxacillin-resistant Staphylococcus aureus (ORSA) in U.S. intensive care units (ICUs): 1992\u20132002 [abstract 74]","volume-title":"Proceedings of the International Conference on Emerging Infectious Diseases (Atlanta)","author":"Klevins","year":"2004"},{"key":"key\n\t\t\t\t20171014021251_ref7","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa043252","article-title":"Methicillin-resistant Staphylococcus aureus disease in three communities","volume":"352","author":"Fridkin","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014021251_ref8","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/jcp.14.4.385","article-title":"Methicillin-resistant staphylococci","volume":"14","author":"Barber","year":"1961","journal-title":"J Clin Pathol"},{"key":"key\n\t\t\t\t20171014021251_ref9","doi-asserted-by":"crossref","first-page":"582","DOI":"10.2307\/30148460","article-title":"Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975\u20131991","volume":"13","author":"Panlilio","year":"1992","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key\n\t\t\t\t20171014021251_ref10","first-page":"1123","article-title":"Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus\u2014Minnesota and North Dakota, 1997\u20131999","volume":"282","author":"Centers for Disease Control Prevention","year":"1999","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20171014021251_ref11","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/jama.1993.03500050076029","article-title":"The epidemiology of intravenous vancomycin usage in a university hospital: a 10-year study","volume":"269","author":"Ena","year":"1993","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20171014021251_ref12","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1086\/383036","article-title":"Frequency of reduced vancomycin susceptibility and heterogeneous subpopulation in persistent or recurrent methicillin-resistant Staphylococcus aureus bacteremia","volume":"38","author":"Khosrovaneh","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014021251_ref13","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJMoa025025","article-title":"Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene","volume":"348","author":"Chang","year":"2003","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014021251_ref14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1086\/346207","article-title":"Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997\u20132001","volume":"36","author":"Fridkin","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014021251_ref15","first-page":"63","article-title":"Vancomycin intermediate and resistant Staphylococcus aureus: what the nephrologist needs to know","volume":"18","author":"McDonald","year":"2004","journal-title":"Nephrol News Issues"},{"key":"key\n\t\t\t\t20171014021251_ref16","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1086\/382357","article-title":"Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure","volume":"38","author":"Whitener","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014021251_ref17","first-page":"322","article-title":"Vancomycin-resistant Staphylococcus aureus\u2014New York, 2004","volume":"53","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20171014021251_ref18","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1128\/AAC.49.1.470-472.2005","article-title":"Comparison of Tn1546-like elements in vancomycin-resistant Staphylococcus aureus isolates from Michigan and Pennsylvania","volume":"49","author":"Clark","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014021251_ref19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1128\/AAC.48.1.275-280.2004","article-title":"Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania","volume":"48","author":"Tenover","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014021251_ref20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM198807213190307","article-title":"Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium","volume":"319","author":"Leclercq","year":"1988","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014021251_ref21","first-page":"597","article-title":"Nosocomial enterococci resistant to vancomycin\u2014United States, 1989\u20131993","volume":"42","author":"Centers for Disease Control Prevention","year":"1993","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20171014021251_ref22","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/01.qco.0000171923.62699.0c","article-title":"Vancomycin-resistant staphylococci and enterococci: epidemiology and control","volume":"18","author":"Tenover","year":"2005","journal-title":"Curr Opin Infect Dis"},{"key":"key\n\t\t\t\t20171014021251_ref23","first-page":"793","article-title":"Methicillin-resistant Staphylococcus aureus infections among competitive sports participants\u2014Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000\u20132003","volume":"52","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20171014021251_ref24","first-page":"992","article-title":"Methicillin-resistant Staphylococcus aureus infections in correctional facilities\u2014Georgia, California, and Texas, 2001\u20132003","volume":"52","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20171014021251_ref25","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3201\/eid1005.030604","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus among military recruits","volume":"10","author":"Zinderman","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20171014021251_ref26","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1086\/379022","article-title":"Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women","volume":"37","author":"Saiman","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014021251_ref27","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1086\/425321","article-title":"Emergence of new strains of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit","volume":"39","author":"Healy","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014021251_ref28","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1086\/313461","article-title":"Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia","volume":"29","author":"Lina","year":"1999","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014021251_ref29","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMoa042683","article-title":"Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles","volume":"352","author":"Miller","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014021251_ref30","first-page":"60","article-title":"Emergence of methicillin-resistant Staphylococcus aureus as a cause of community-acquired pneumonia during the influenza season, 2003\u20134 [abstract LB-8]","volume-title":"Proceedings of the 42nd Annual Meeting of the Infectious Diseases Society of America (Boston)","author":"Hageman","year":"2004"},{"key":"key\n\t\t\t\t20171014021251_ref31","article-title":"Bad bugs, no drugs","volume-title":"Infectious Diseases Society of America","author":"Infectious Diseases Society of America","year":"2005"},{"key":"key\n\t\t\t\t20171014021251_ref32","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1086\/502306","article-title":"Rapidly rising prevalence of nosocomial multidrug-resistant, gram-negative bacilli: a 9-year surveillance study","volume":"25","author":"D`Agata","year":"2004","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key\n\t\t\t\t20171014021251_ref33","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1345\/aph.1D592","article-title":"Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians","volume":"38","author":"Jain","year":"2004","journal-title":"Ann Pharmacother"},{"key":"key\n\t\t\t\t20171014021251_ref34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1086\/313902","article-title":"Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage","volume":"31","author":"Manikal","year":"2000","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014021251_ref35","first-page":"1063","article-title":"Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002\u20132004","volume":"53","author":"Centers for Disease Control Prevention","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20171014021251_ref36","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1086\/342577","article-title":"Molecular epidemiology of a citywide outbreak of extended-spectrum \u03b2-lactamase-producing Klebsiella pneumoniae infection","volume":"35","author":"Quale","year":"2002","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014021251_ref37","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1128\/AAC.45.4.1151-1161.2001","article-title":"Novel carbapenem-hydrolyzing \u03b2-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae","volume":"45","author":"Yigit","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014021251_ref38","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.1128\/AAC.48.11.4438-4440.2004","article-title":"Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 in an Enterobacter sp","volume":"48","author":"Hossain","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014021251_ref39","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1128\/AAC.48.12.4793-4799.2004","article-title":"Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A \u03b2-lactamase, KPC-3, in a New York Medical Center","volume":"48","author":"Woodford","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014021251_ref40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1086\/421495","article-title":"Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 \u03b2-lactamases in New York City","volume":"39","author":"Bradford","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014021251_ref41","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.idc.2004.04.007","article-title":"Current use for old antibacterial agents: polymyxins, rifampin, and aminoglycosides","volume":"18","author":"Kaye","year":"2004","journal-title":"Infect Dis Clin North Am"},{"key":"key\n\t\t\t\t20171014021251_ref42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-5-1","article-title":"Toxicity after prolonged (more than four weeks) administration of intravenous colistin","volume":"5","author":"Falagas","year":"2005","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20171014021251_ref43","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1086\/383045","article-title":"Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987\u20132001","volume":"189","author":"Archibald","year":"2004","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171014021251_ref44","first-page":"67","article-title":"Increasing incidence of Clostridium difficile-associated disease in U.S. acute care hospitals, 1993\u20132001 [abstract 45]","volume-title":"Proceedings of the 14th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America (Philadelphia)","author":"McDonald","year":"2004"},{"key":"key\n\t\t\t\t20171014021251_ref45","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00000658-200203000-00008","article-title":"Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications","volume":"235","author":"Dallal","year":"2002","journal-title":"Ann Surg"},{"key":"key\n\t\t\t\t20171014021251_ref46","first-page":"77","article-title":"Perceived increases in the incidence and severity of Clostridium difficile disease: an emerging threat that continues to unfold [abstract 66]","volume-title":"Proceedings of the 14th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America (Los Angeles)","author":"Layton","year":"2005"},{"key":"key\n\t\t\t\t20171014021251_ref47","first-page":"59","article-title":"Emergence of an epidemic strain of Clostridium difficile in the United States 2001\u20134: potential role for virulence factors and antimicrobial resistance traits [abstract LB-2]","volume-title":"Proceedings of the 42nd Annual Meeting of the Infectious Diseases Society of America (IDSA) (Boston)","author":"McDonald","year":"2004"},{"key":"key\n\t\t\t\t20171014021251_ref48","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0140-6736(05)67420-X","article-title":"Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe","volume":"366","author":"Warny","year":"2005","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171014021251_ref49","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1086\/381551","article-title":"Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use","volume":"38","author":"Gaynes","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014021251_ref50","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1086\/430315","article-title":"Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada","volume":"40","author":"Pepin","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014021251_ref51","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1086\/430317","article-title":"Metronidazole for Clostridium difficile-associated disease: is it okay for mom?","volume":"40","author":"Gerding","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014021251_ref52","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3201\/eid0808.010418","article-title":"Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus","volume":"8","author":"Carmeli","year":"2002","journal-title":"Emerg Infect Dis"},{"issue":"Suppl 2","key":"key\n\t\t\t\t20171014021251_ref53","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1086\/516247","article-title":"Is there a relationship between vancomycin-resistant enterococcal infection and Clostridium difficile infection?","volume":"25","author":"Gerding","year":"1997","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014021251_ref54","author":"Centers for Disease Control and Prevention: Get smart: know when antibiotics work"},{"key":"key\n\t\t\t\t20171014021251_ref55","author":"Centers for Disease Control and Prevention: Campaign to prevent antimicrobial resistance in healthcare settings"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/42\/Supplement_2\/S65\/20907017\/42-Supplement_2-S65.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,14]],"date-time":"2017-10-14T02:13:01Z","timestamp":1507947181000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/42\/Supplement_2\/S65\/377160\/Trends-in-Antimicrobial-Resistance-in-Health"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,15]]},"references-count":55,"journal-issue":{"issue":"Supplement_2","published-online":{"date-parts":[[2006,1,15]]},"published-print":{"date-parts":[[2006,1,15]]}},"URL":"https:\/\/doi.org\/10.1086\/499404","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,1,15]]},"published":{"date-parts":[[2006,1,15]]}}}